Email your diabetes stories to editor Oliver Jelley.

Join the expanding diabetes community on Twitter and follow us for the latest diabetes news updates at @DiabetesTimes.

It's all very weird. Debate about seven-day NHS has started to walk into Pythonesque territory now. To start with, a seven-day NHS is absolutely what is needed... but somehow we need to get past the belief that the NHS exists only within a hospital. Talk about safe staffing, talk about seven-day working... the debate is mostly centred around hospitals... which is a bit odd – given that the bulk of NHS is based in the community!

Look at it... health economists are saying it; think tanks are saying it... let's forget for a moment what the BMA is saying... (as that provokes various debates about vested interests)... but the message is loud and clear... in an era of cash-strapped environments, the more cost effective way of doing things is to invest in the community. 

Everyone, or at least most importantly, Mr Hunt, seems to have at least agreed that implementing a seven-day service will need significant amount of investment – but as a diabetes specialist, I am baffled. To begin with, I was told there was no money... fair enough... so we walked down the road of discussing tough choices, thinking of prioritisation... now I am being told, there is money but for... what is it... elective work? To read more, click here.

A drug used to treat diabetes could help beat leukaemia, early research in the journal Nature suggests.

During the trial scientists at the University of Paris gave pioglitazone, which is traditionally given to people with type 2 diabetes, to patients with chronic myeloid leukaemia (CML), alongside standard treatment. To read more, click here.

Sanofi’s Toujeo® (Insulin glargine 300 units/mL) has been approved for use in Scotland, the pharmaceutical company has announced. To read more, click here.

The first symposium in Europe to focus on silent occlusions and infusion set failures is set to take place later this month.

The event, which will also focus on optimising insulin pump therapy, will be held ahead of the 51st European Association for the Study of Diabetes (EASD) Annual Meeting on September, 14, in Stockholm. To read more, click here.

The UK’s largest community website and forum for people living with diabetes has reached more than 160,000 members.

The total means that diabetes.co.uk is now reaching five per cent of the 3.2 million people who have diabetes in the UK. To read more, click here.

The latest innovations and successes in the care of diabetes and older people will be showcased at a conference in November.

The third National Conference of the Older People’s Diabetes Network (OPDN) will take place in Birmingham on Friday, November 13. To read more, click here.

A diabetes professor from Leicester has been named as one of the country’s leading GPs in a prestigious list.

Professor Kamlesh Khunti has been heralded as a “GP diabetes champion” after being installed at number 25 of the Pulse Power 50. To read more, click here.

Weight loss surgery can help control the long-term effects of type 2 diabetes, according to new research.

A study, conducted by the King’s College London and Rome’s Universita Cattolica, suggested the surgery improves symptoms both through weight loss and by changing the way the gut functions.  To read more, click here.